Charles River Laboratories
George Llado is an accomplished executive with extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as a Member of the Board of Directors at TileDB and TraceLink, and as a Director and Board Member at Charles River Laboratories, Llado has significantly contributed to organizations focused on supply chain solutions and biotechnology. Previously, Llado held the position of Senior Vice President and Chief Information Officer at Alexion Pharmaceuticals, Inc., and spent over two decades at Merck & Co., Inc. as a Vice President. In addition to board roles, Llado is a Visiting Faculty Member at World 50 Group since 2011. Educational credentials include a Bachelor of Science in Computer Science from New York Institute of Technology and ongoing participation in the Dr. James I. Cash CIO Leadership Program at Harvard Business School.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.